Correlation Between Valneva SE and Rapport Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Valneva SE and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Rapport Therapeutics,.

Diversification Opportunities for Valneva SE and Rapport Therapeutics,

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Valneva and Rapport is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Valneva SE i.e., Valneva SE and Rapport Therapeutics, go up and down completely randomly.

Pair Corralation between Valneva SE and Rapport Therapeutics,

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.49 times more return on investment than Rapport Therapeutics,. However, Valneva SE ADR is 2.06 times less risky than Rapport Therapeutics,. It trades about 0.21 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.34 per unit of risk. If you would invest  399.00  in Valneva SE ADR on October 21, 2024 and sell it today you would earn a total of  38.00  from holding Valneva SE ADR or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Rapport Therapeutics, Common

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Rapport Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rapport Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Valneva SE and Rapport Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Rapport Therapeutics,

The main advantage of trading using opposite Valneva SE and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.
The idea behind Valneva SE ADR and Rapport Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation